An Evaluation of the Safety and Tolerability of Ocular Lubricants
ConditionDry Eye Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlcon Research
About this trial
The purpose of this study is to evaluate the safety and tolerability of two new artificial tear formulations in subjects with moderate dry eye disease.
Eligibility criteria
Qualifiers
Subject must be willing and able to understand and sign an ethics committee approved informed consent form.
Subject must be willing and able to attend all study visits as required by the protocol.
Subject must exhibit symptoms of dry eye at the Screening Visit.
Subject must currently use artificial tears.
Disqualifiers
Has any known active ocular disease and/or infection.
Has any known infection or inflammation that requires treatment or has a systemic condition that, in the opinion of the investigator, may affect a study outcome variable.
Any ocular injury to either eye in the 12 weeks prior to screening.
Current wearer of contact lenses or has a history of contact lens wear within the previous 1 month.
Trial design
Treatments tested in this trial
- FID123440 test formulation
- FID123437 test formulation
- FID123440 test formulation
Treatment groups
148 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov